治療薬モニタリング市場：製品、技術、薬剤クラス別、エンドユーザー別- 世界予測2024-2030年

治療薬モニタリング市場規模は2023年に37億9,000万米ドルと推計され、2024年には43億8,000万米ドルに達し、CAGR 16.11％で2030年には107億8,000万米ドルに達すると予測されます。

治療薬モニタリングは、血漿、血清、血液中の薬物濃度を測定する臨床検査プロセスです。これらの治療薬モニタリングプロセスにより、患者固有の投与レジメンの設計、薬剤の有効性の最適化、患者の体内の薬剤物質の一定レベルの維持が可能になります。慢性疾患の増加、ヘルスケアや製薬業界の成長により、治療薬モニタリングは医薬品の安全性と有効性を効果的にモニターする必要性が生じています。しかし、熟練した検査技師の数が限られており、償還政策が不十分であることが市場の成長を妨げています。さらに、イムノアッセイやその他の治療薬モニタリング技術の市場開拓が市場成長の機会を生み出しています。

製品効率的な医薬品管理のためのデータ管理サービスに対する需要の高まり

消耗品には、試薬、キット、検量線など、薬剤レベル検査の精度を高めるために不可欠な使い捨て品が含まれ、繰り返し使用されるため需要が高まっています。データ管理サービスは極めて重要であり、TDMプロセスから得られる膨大なデータを効率的に処理するための高度なソリューションを提供します。データ収集、分析、報告用に設計されたソフトウェアやシステムも含まれ、重要な患者情報や治療情報の合理的な管理を保証します。機器分野には、特異的かつ高感度な薬物検出のためのクロマトグラフィー＆MS検出器、広範な生化学検査のための臨床化学分析器、迅速かつ効果的な薬物定量のための免疫測定分析器など、さまざまな分析器や検出器が含まれます。

エンドユーザー：正確な薬剤管理が不可欠な病院からの需要の増加

病院の検査室は、特に治療指数が狭い、毒性が高い、薬物の代謝や作用に個人差があるなどの理由で正確な投与が必要な治療において、患者ケアの精緻化に役立っています。このアプローチは、患者の生存と回復に正確な薬剤管理が不可欠な急性期医療の場面や、腫瘍学や移植医療などの専門分野では不可欠です。民間検査室は、より幅広い外来患者を対象としており、プライマリ・ケアや専門医と密接に協力し、メンタルヘルス、心血管疾患、自己免疫疾患などの長期疾患を管理しています。民間検査施設はタイムリーな薬物レベルの評価を提供し、投与量の変更や薬剤の選択について医師が十分な知識を持った判断を下せるよう導くことで、患者に合わせた効果的な治療計画を実現する上で欠かせない存在となっています。

地域別の洞察

市場情勢は、臓器移植需要の増加、高精度医薬品の使用、病院ラボや民間ラボを含むヘルスケア分野におけるTDMの応用により、南北アメリカで高度に進化しています。慢性疾患の有病率が上昇し、個別化薬物療法への消費者志向が高まっていることから、APACおよびEMEA地域では医薬品開発プロセスにおける治療薬モニタリングの需要が大幅に増加しています。欧州政府は、投資と資金調達の増加につながる新しい個別化医療の開発を目的とした研究開発枠組み計画の立ち上げに重点を移しています。世界各国政府は、さまざまなタイプの医薬品開発のためのゲノム研究活動の加速に注力しており、TDMの臨床的な利点を認識することで、投薬による副作用を最小限に抑えてより良い治療結果を得るために、世界中の病院からTDMの需要が高まると予想されます。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは治療薬モニタリング市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、治療薬モニタリング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.治療薬モニタリング市場の市場規模および予測は？

2.治療薬モニタリング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.治療薬モニタリング市場の技術動向と規制枠組みは？

4.治療薬モニタリング市場における主要ベンダーの市場シェアは？

5.治療薬モニタリング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個別化医療の需要増加
    • さまざまな治療分野で治療薬モニタリングの採用が増加
    • 固形臓器移植患者における使用と重要性の高まり
  • 抑制要因
    • 不十分な払い戻しポリシー
    • 多額の資本投資の必要性
  • 機会
    • 発展途上国における治療薬モニタリングの将来展望
    • 免疫測定法およびその他の治療薬モニタリング技術の発展
  • 課題
    • 臨床上の課題と熟練した検査技師の不足
• 市場セグメンテーション分析
  • 製品：効率的な医薬品管理のためのデータ管理サービスの需要の高まり
  • エンドユーザー：正確な薬剤管理が不可欠な病院からの需要増加
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 治療薬モニタリング市場：製品別

• 消耗品
• データ管理サービス
• 装置

第7章 治療薬モニタリング市場：技術別

• クロマトグラフィー-MS
• 免疫学的検査
• プロテオーム技術

第8章 治療薬モニタリング市場薬剤クラス別

• 抗不整脈薬
• 抗生物質
• 抗てんかん薬
• 気管支拡張薬
• 免疫抑制薬
• 向精神薬

第9章 治療薬モニタリング市場：エンドユーザー別

• 病院の検査室
• プライベートラボ

第10章 南北アメリカの治療薬モニタリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の治療薬モニタリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの治療薬モニタリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • CapitainerがAstraZenecaとの提携を発表。
  • Novo Holdingsがプロテオミクス技術企業Evosepに投資。
  • AegirBio ABは、TDMや唾液サンプル採取などへの投資を強化するために、ワラント付 5,500万スウェーデンクローナの転換社債に関してAtlas Special Opportunities, LLCと契約を締結しました。
  • 治療薬モニタリング分析のための臨床LC-MS法。
  • Boditech Medは4つのTDM製品の輸出ライセンスを取得しました。
  • Pace社、GC-MS/MS技術によるダイオキシンおよびジベンゾフランの検出方法についてEPAの承認を取得。
  • Bio-Rad社、バイオ分析および薬物モニタリング用の抗イディオタイプ抗体の製品範囲を拡大。
  • Beckman Coulter社とSaladax Biomedical社が抗精神病薬治療薬モニタリングで提携。
  • Ampersand Capital Partnersが、大手SIFT-MSソリューションプロバイダーであるSyft Technologiesに投資しました。

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. THERAPEUTIC DRUG MONITORING MARKET RESEARCH PROCESS
• FIGURE 2. THERAPEUTIC DRUG MONITORING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. THERAPEUTIC DRUG MONITORING MARKET DYNAMICS
• FIGURE 7. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. THERAPEUTIC DRUG MONITORING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. THERAPEUTIC DRUG MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. THERAPEUTIC DRUG MONITORING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY & MS DETECTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY & MS DETECTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GC-MS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GC-MS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY LC-MS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY LC-MS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY RADIOIMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY RADIOIMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIEPILEPTIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIEPILEPTIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY BRONCHODILATOR DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY BRONCHODILATOR DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANT DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANT DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PSYCHOACTIVE DRUGS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PSYCHOACTIVE DRUGS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 73. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 74. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 85. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 86. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 87. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 88. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 89. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 90. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 91. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 92. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 93. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 94. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 95. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 100. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 101. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 102. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 103. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 104. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 105. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 106. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 107. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 108. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 109. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 110. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 111. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 112. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 113. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 114. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 115. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 116. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 117. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 118. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 119. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 120. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 121. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 122. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 123. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 124. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 125. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 126. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 127. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 128. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 129. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 130. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 131. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 132. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 133. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 134. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 135. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 136. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 137. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 138. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 139. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 140. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 141. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 142. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 143. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 144. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 145. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 146. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 147. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 148. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 149. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 150. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 151. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 154. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 155. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 156. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 157. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 158. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 159. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 160. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 161. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 162. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 164. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 166. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 170. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 171. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 172. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 173. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 174. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 175. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 176. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 177. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 178. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 179. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 180. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 181. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 182. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 183. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 188. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 189. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 190. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 191. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 192. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 193. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 194. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 195. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 196. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 197. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 198. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 199. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 200. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 201. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 202. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 203. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 204. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 205. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 206. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 207. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 208. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 209. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 210. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 211. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 212. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 213. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 214. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 215. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 216. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 217. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 218. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 219. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 220. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 221. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 222. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 223. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 224. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 225. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 228. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 229. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 230. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 231. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 232. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 233. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 234. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 235. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 236. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 237. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 238. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 239. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 240. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 241. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 242. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 243. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 244. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 245. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 246. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 247. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 248. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 249. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 250. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 251. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 252. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 253. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 254. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 255. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 256. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 257. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 258. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 259. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 260. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 261. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 262. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 263. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 264. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 265. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 266. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 267. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 270. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 271. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 272. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 273. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 274. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 275. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 276. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 277. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 278. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 279. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 280. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 281. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 284. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 285. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 286. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 287. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 288. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 289. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 290. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 291. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 292. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 293. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 294. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 296. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 297. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 298. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 299. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 300. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 301. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 302. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 303. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 304. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 305. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 306. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 307. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
• TABLE 308. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
• TABLE 309. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 310. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 311. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 312. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 313. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 314. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 315. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 316. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 317. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2023 (USD MILLION)
• TABLE 318. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2024-2030 (USD MILLION)
• TABLE 319. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2023 (USD MILLION)
• TABLE 320. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2024-2030 (USD MILLION)
• TABLE 321. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2

[196 Pages Report] The Therapeutic Drug Monitoring Market size was estimated at USD 3.79 billion in 2023 and expected to reach USD 4.38 billion in 2024, at a CAGR 16.11% to reach USD 10.78 billion by 2030.

Therapeutic drug monitoring is the clinical testing process of measuring plasma, serum, or blood drug concentrations. These therapeutic drug monitoring processes enable designing the patient-specific dosage regimen, optimizing the effectiveness of drugs, and maintaining a certain level of drug substance in patients' bodies. The increase in chronic disease incidences and growth in the healthcare and pharmaceutical industries create the need for therapeutic drug monitoring to monitor drug dosage safety and efficacy effectively. However, the limited availability of skilled laboratory technicians and inadequate reimbursement policies is hampering the growth of the market. Furthermore, the developments in immunoassay and other therapeutic drug monitoring technologies are creating opportunities for market growth.

Product: Rising demand for data management services for efficient drug management

Consumables include indispensable disposable items such as reagents, kits, and calibrators, crucial for the accuracy of drug-level tests, and witness a growing demand due to their repetitive use. Data management services are pivotal, offering advanced solutions for efficiently handling the extensive data yielded from TDM processes, including software and systems designed for data collection, analysis, and reporting, ensuring streamlined management of crucial patient and treatment information. The equipment segment encompasses various analyzers and detectors, such as chromatography & MS Detectors for specific and sensitive drug detection, clinical chemistry analyzers for broad biochemical testing, and immunoassay analyzers for quick and effective drug quantification.

End-User: Increasing demand from hospitals where accurate drug management is essential

Hospital labs are instrumental in refining patient care, particularly for treatments requiring precise dosing due to the narrow therapeutic index, high toxicity, or individual variations in drug metabolism and action. This approach is essential in acute care scenarios and specialties such as oncology and transplant medicine, where accurate drug management is crucial to patient survival and recovery. Private laboratories cater to a broader outpatient population, collaborating closely with primary care and specialty physicians to manage long-term conditions, including mental health, cardiovascular, and autoimmune diseases. Private laboratories provide timely drug-level assessments and are indispensable in guiding physicians toward making educated decisions on dosage modifications and medication selection, thereby ensuring tailored and efficacious patient treatment plans.

Regional Insights

The therapeutic drug monitoring market shows a highly evolving landscape in the Americas owing to the increasing demand for organ transplantation, usage of precision medicines, and applications of TDM in healthcare areas, including hospital labs and private labs. The rising prevalence of chronic diseases, and increasing consumer switch towards personalized medications, tremendously increase the demand for therapeutic drug monitoring for drug development process in APAC and EMEA regions. European governments have shifted their focus towards launching the Framework Programme for Research and Technological Development, which aims to develop new personalized medicine leading to a rise in investment and funding. Governments worldwide are focusing on accelerating genomic research activities for the development of different types of drugs, and recognizing the clinical benefits of therapeutic drug monitoring is expected to raise demand for TDM from hospitals worldwide for better treatment outcomes with minimum side effects from the medication.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Therapeutic Drug Monitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Therapeutic Drug Monitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Drug Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., apDia Group, ARK Diagnostics, Inc., ARUP Laboratories, Assay Genie, Bio-Rad Laboratories, Inc., bioMerieux SA, Buhlmann Laboratories AG, Cambridge Life Sciences Limited, Cardinal Health, Inc., Chromsystems Instruments & Chemicals GmbH, Danaher Corporation, DiaSorin SpA, DiaSystem Scandinavia AB, Eagle Biosciences, Inc., Exagen Inc., F. Hoffmann-La Roche AG, Grifols, S.A., H.U. Group Holdings, Inc., Krishgen Biosystems, Merck KGaA, Myriad Genetics, Inc., Neoteryx, LLC by Trajan Group, OneCare Media, LLC, Pfizer Inc., R-Biopharm AG, Randox Laboratories, Ltd., Sekisui Chemical Co Ltd., Siemens Healthineers AG, Svar Life Science AB, Tecan Trading AG, Theradiag SA, Thermo Fisher Scientific, Inc., and Veolia Group.

Market Segmentation & Coverage

This research report categorizes the Therapeutic Drug Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Consumables
  • Data Management Services
  • Equipment
    • Chromatography & MS Detectors
    • Clinical Chemistry Analyzers
    • Immunoassay Analyzers
• Technology
  • Chromatography-MS
    • GC-MS
    • LC-MS

• Immunoassays
  • Chemiluminescence Immunoassays
  • Colorimetric Immunoassays
  • Fluorescence Immunoassays
  • Radioimmunoassays

• Proteomic Technologies

• Drug Class
  • Antiarrhythmic Drugs
  • Antibiotic Drugs
  • Antiepileptic Drugs
  • Bronchodilator Drugs
  • Immunosuppressant Drugs
  • Psychoactive Drugs

• End-User
  • Hospital Labs
  • Private Labs

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Therapeutic Drug Monitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Therapeutic Drug Monitoring Market?

3. What are the technology trends and regulatory frameworks in the Therapeutic Drug Monitoring Market?

4. What is the market share of the leading vendors in the Therapeutic Drug Monitoring Market?

5. Which modes and strategic moves are suitable for entering the Therapeutic Drug Monitoring Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased Demand for Personalized Medicine
    • 5.1.1.2. Rising Adoption of Therapeutic Drug Monitoring Across Various Therapeutic Fields
    • 5.1.1.3. Growing Use and Importance in Patients with Solid Organ Transplantation
  • 5.1.2. Restraints
    • 5.1.2.1. Inadequate Reimbursement Policies
    • 5.1.2.2. Need of High Capital Investments
  • 5.1.3. Opportunities
    • 5.1.3.1. Future Perspectives of Therapeutic Drug Monitoring in Developing Nations
    • 5.1.3.2. Developments in Immunoassay and Other Therapeutic Drug Monitoring Technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Clinical Challenges and Limited Availability of Skilled Laboratory Technicians
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising demand for data management services for efficient drug management
  • 5.2.2. End-User: Increasing demand from hospitals where accurate drug management is essential
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Therapeutic Drug Monitoring Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Data Management Services
• 6.4. Equipment

7. Therapeutic Drug Monitoring Market, by Technology

• 7.1. Introduction
• 7.2. Chromatography-MS
• 7.3. Immunoassays
• 7.4. Proteomic Technologies

8. Therapeutic Drug Monitoring Market, by Drug Class

• 8.1. Introduction
• 8.2. Antiarrhythmic Drugs
• 8.3. Antibiotic Drugs
• 8.4. Antiepileptic Drugs
• 8.5. Bronchodilator Drugs
• 8.6. Immunosuppressant Drugs
• 8.7. Psychoactive Drugs

9. Therapeutic Drug Monitoring Market, by End-User

• 9.1. Introduction
• 9.2. Hospital Labs
• 9.3. Private Labs

10. Americas Therapeutic Drug Monitoring Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Therapeutic Drug Monitoring Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Therapeutic Drug Monitoring Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Capitainer announces collaboration with AstraZeneca.
  • 13.3.2. Novo Holdings invests in proteomics technology company, Evosep.
  • 13.3.3. AegirBio AB enters into an agreement with Atlas Special Opportunities, LLC regarding convertible bonds of SEK 55 million with attached warrants to intensify investments in i.a. TDM and saliva sampling.
  • 13.3.4. Clinical LC-MS methods for therapeutic drug monitoring analysis.
  • 13.3.5. Boditech Med has obtained the export license of four TDM products.
  • 13.3.6. Pace Obtains EPA Approval on Method for Detecting Dioxins and Dibenzofurans Through GC-MS/MS Technology.
  • 13.3.7. Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring.
  • 13.3.8. Beckman Coulter and Saladax Biomedical Team Up on Antipsychotic Therapeutic Drug Monitoring.
  • 13.3.9. Ampersand Capital Partners Invests in Syft Technologies, Leading SIFT-MS Solutions Provider.

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio